Naltrexone Treatment Centers in Texas

Yes. MAT with methadone or buprenorphine is the recommended standard of care in pregnancy — ACOG and SAMHSA both endorse it. Texas providers coordinate with obstetrics to monitor mother and baby throughout pregnancy and the neonatal period.

Many Texas community behavioral-health agencies and federally qualified health centers offer sliding-scale fees based on household income. Sliding-scale fees commonly bring a weekly methadone visit down to $5–$25. Ask naltrexone providers in your area about discounted rates when you call.

Texas Medicaid copays for MAT visits are typically $0–$3, and are often waived for patients with behavioral-health conditions. Pharmacy copays for buprenorphine or naltrexone prescriptions follow the same schedule.

Yes. Parity law requires equal coverage for the medication and counseling components of MAT. Counseling copays often match mental-health visit copays (typically $20–$50 for commercial plans in Texas). Providers bill counseling and medication separately.

For methadone, SAMHSA’s 2024 final rule allows OTPs in Texas to grant up to 28 days of take-home doses once clinical-stability criteria are met. For buprenorphine, 30-day prescriptions are standard and 90-day fills are permitted in many Texas plans. Long-acting naltrexone is a single monthly injection, so no take-home supply applies.

Many Texas patients stay on naltrexone for a year or more, and some stay indefinitely. Duration depends on individual stability, quality of life, and risk of relapse. Research consistently shows that longer MAT duration is associated with lower overdose mortality.

Use the SAMHSA treatment locator at findtreatment.gov, filter by Texas, and search for medications offered. You can also browse our directory of naltrexone providers filtered to Texas, or call 988 for live referrals from a trained counselor.

Yes. Records are protected by 42 CFR Part 2, which is stricter than HIPAA. Your employer, family, or law enforcement cannot access your records without your specific written consent or a narrowly tailored court order. Confidentiality applies from the first visit onward.

Long-term opioid-agonist therapy (methadone, buprenorphine) can lower testosterone in some men and affect menstruation in some women. Annual hormone panels are reasonable. Switching medications or adjusting dose resolves most cases; endocrinology referral is available in Texas for persistent issues.

Yes. Starting MAT during pregnancy is strongly recommended for patients with OUD. Texas perinatal-addiction programs offer priority same-day access; OB-MAT coordinated care improves maternal and infant outcomes dramatically compared to untreated OUD.

No. Attending 12-step programs is optional; SMART Recovery, Women for Sobriety, Refuge Recovery, and secular support groups are all acceptable alternatives. Texas MAT clinicians can help you match with a peer group aligned to your values.

No. There is no public registry of MAT patients. Texas’s prescription drug monitoring program (PDMP) tracks controlled-substance prescriptions but is accessible only to clinicians and law enforcement with a specific investigative basis.